Officials in Canada said on 25 February 2021 that Canada's COVID-19 vaccination campaign is ramping up after earlier supply disruptions, Reuters news agency reported on Friday.
Canada's deputy chief public health officer, Howard Njoo, was quoted as telling a briefing that over 240,000 COVID-19 doses were injected last week, the most in more than a month.
"We are seeing positive signs that the rollout is ramping up. ... This is a reflection of greater supply," he said, adding that about 2.9% of Canadians had received at least one dose and this percentage is expected to significantly increase throughout March 2021.
Major General Dany Fortin, in charge of coordinating the COVID-19 vaccine rollout, has said a total of 643,000 doses had been distributed this week, the highest amount yet.
Reportedly, Canada has deals with US pharmaceutical companies Pfizer Inc and Moderna Inc to purchase COVID-19 vaccines, but both companies ran into production problems last month and reduced shipments.
Canada says it is still on track to receive a total of six million doses from Pfizer and Moderna by the end of March 2021 and that anyone who wants a shot can get one by the end of September 2021.
So far, Canada has recorded a total of 21,807 COVID-19 deaths and 855,126 cases.
EpiVax introduces AI-enhanced models for immunogenicity prediction
Pfizer and BioNTech granted FDA approval for XFG-adapted COVID-19 vaccine
4basebio announces strategic collaboration with Genezen
Charles River and Medigen collaborate on next-generation enterovirus vaccine development
Piramal Pharma acquires controlling stake in Yapan Bio
Innorna Nominated for 2026 Prix Galien USA Best Startup Award
Sanofi's MenQuadfi receives EU approval for infants from six weeks
Evaxion to present three-year cancer vaccine data at ESMO Congress 2026
Evaxion presents new preclinical data on cytomegalovirus vaccine EVX-V1
Northwest Biotherapeutics presents on propensity score matching at BNOS 2026
Taiwan biomedical startups hold over 100 business meetings at BIO 2026
SK bioscience to lead Gates Foundation-funded ROTOR project
Anixa Biosciences' breast cancer vaccine technology granted first Korean patent
Transgene expands myvac platform into non-small cell lung cancer with TG4070